228 related articles for article (PubMed ID: 8551577)
1. SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element.
McNally LM; McNally MT
J Virol; 1996 Feb; 70(2):1163-72. PubMed ID: 8551577
[TBL] [Abstract][Full Text] [Related]
2. A cellular protein, hnRNP H, binds to the negative regulator of splicing element from Rous sarcoma virus.
Fogel BL; McNally MT
J Biol Chem; 2000 Oct; 275(41):32371-8. PubMed ID: 10934202
[TBL] [Abstract][Full Text] [Related]
3. An RNA splicing enhancer-like sequence is a component of a splicing inhibitor element from Rous sarcoma virus.
McNally LM; McNally MT
Mol Cell Biol; 1998 Jun; 18(6):3103-11. PubMed ID: 9584151
[TBL] [Abstract][Full Text] [Related]
4. Efficient polyadenylation of Rous sarcoma virus RNA requires the negative regulator of splicing element.
Fogel BL; McNally LM; McNally MT
Nucleic Acids Res; 2002 Feb; 30(3):810-7. PubMed ID: 11809895
[TBL] [Abstract][Full Text] [Related]
5. SR protein and snRNP requirements for assembly of the Rous sarcoma virus negative regulator of splicing complex in vitro.
Cook CR; McNally MT
Virology; 1998 Mar; 242(1):211-20. PubMed ID: 9501036
[TBL] [Abstract][Full Text] [Related]
6. Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus.
Maciolek NL; McNally MT
J Virol; 2007 Oct; 81(20):11208-17. PubMed ID: 17670832
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional analysis of the Rous Sarcoma virus negative regulator of splicing and demonstration of its activation by the 9G8 SR protein.
Bar A; Marchand V; Khoury G; Dreumont N; Mougin A; Robas N; Stévenin J; Visvikis A; Branlant C
Nucleic Acids Res; 2011 Apr; 39(8):3388-403. PubMed ID: 21183462
[TBL] [Abstract][Full Text] [Related]
9. Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers.
Zheng ZM; He PJ; Baker CC
J Virol; 1997 Dec; 71(12):9096-107. PubMed ID: 9371566
[TBL] [Abstract][Full Text] [Related]
10. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
[TBL] [Abstract][Full Text] [Related]
11. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.
Bourgeois CF; Popielarz M; Hildwein G; Stevenin J
Mol Cell Biol; 1999 Nov; 19(11):7347-56. PubMed ID: 10523623
[TBL] [Abstract][Full Text] [Related]
12. U1 small nuclear ribonucleoprotein and splicing inhibition by the rous sarcoma virus negative regulator of splicing element.
McNally LM; McNally MT
J Virol; 1999 Mar; 73(3):2385-93. PubMed ID: 9971822
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the negative regulator of splicing element and a 3' splice site: requirement for U1 small nuclear ribonucleoprotein and the 3' splice site branch point/pyrimidine tract.
Cook CR; McNally MT
J Virol; 1999 Mar; 73(3):2394-400. PubMed ID: 9971823
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the regions of the Rous sarcoma virus 3' splice sites: implications for regulation of alternative splicing.
Berberich SL; Stoltzfus CM
J Virol; 1991 May; 65(5):2640-6. PubMed ID: 1850037
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Rous sarcoma virus RNA splicing and stability.
Arrigo S; Beemon K
Mol Cell Biol; 1988 Nov; 8(11):4858-67. PubMed ID: 2850470
[TBL] [Abstract][Full Text] [Related]
16. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
Chung H ; Derse D
J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
Wang J; Manley JL
RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
[TBL] [Abstract][Full Text] [Related]
18. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.
Tacke R; Manley JL
EMBO J; 1995 Jul; 14(14):3540-51. PubMed ID: 7543047
[TBL] [Abstract][Full Text] [Related]
19. Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production.
Jacquenet S; Decimo D; Muriaux D; Darlix JL
Retrovirology; 2005 May; 2():33. PubMed ID: 15907217
[TBL] [Abstract][Full Text] [Related]
20. The role of overlapping U1 and U11 5' splice site sequences in a negative regulator of splicing.
Hibbert CS; Gontarek RR; Beemon KL
RNA; 1999 Mar; 5(3):333-43. PubMed ID: 10094303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
